Join the Debate: Healthcare vs. Health Care
STAT is seeking input on whether to adopt 'healthcare' or 'health care' in its publications. Your opinion matters.
STAT is seeking input on whether to adopt 'healthcare' or 'health care' in its publications. Your opinion matters.
The FDA commissioner highlights how real-time clinical trials could change the landscape of drug development by providing regulators with immediate data insights.
Industry leaders express significant worries regarding the implications of Trump's drug pricing plan, while Purdue Pharma's sentencing underscores persistent challenges in the pharmaceutical sector.
Experts argue that neglecting mental illness in conversations about brain health limits our understanding and potential for improvement in this critical area.
A recent recommendation to limit hepatitis B vaccinations at birth to only those infants deemed at risk raises alarms about potential increases in infections among newborns.
Erasca has reported that its experimental treatment for pancreatic and lung cancers has delivered results that exceed initial expectations in early trials.
Robert F. Kennedy Jr. has reportedly failed to provide answers to Democrats' inquiries, particularly regarding a controversial contract, leading to increased frustrations.
The Trump administration has expressed concerns regarding the use of federal funds for fentanyl test strips, indicating a shift away from harm reduction strategies.
Recent research highlights the importance of a five-gene protein in aiding plant growth during the critical seedling phase, potentially influencing agricultural practices.
Archelle Georgiou, a former insider at a major health insurer, discusses the objectives behind prior authorization processes in healthcare.
Astellas is moving forward with its XLMTM gene therapy trials despite earlier reports of deaths. Meanwhile, Veradermics celebrates success in its hair loss pill trial, and the FDA accelerates reviews for psychedelics.
As GLP-1 medications become more common for weight management, concerns about their effects on eating behaviors are emerging. Ongoing research aims to clarify these risks.
An integrative medicine doctor, who is married to the acting U.S. attorney general, has been appointed to a significant NIH advisory council responsible for funding decisions.
Recent findings suggest that microplastics, which we encounter daily through air and food, may interact with our gut microbiome, raising potential health concerns.
A games developer has been named as the individual who attempted to enter a dinner attended by former President Trump, raising questions about security at such events.
Nancy Cox, a prominent figure in influenza research and a veteran at the CDC, has passed away at the age of 77, leaving behind a significant legacy in public health.
A recent report from the American Lung Association indicates that nearly half of children in the US are exposed to harmful air pollution levels, coinciding with the EPA's rollback of environmental safeguards.
MarketWatch provides insights for investors contemplating the financial implications of the ongoing Iran war, highlighting key indicators to consider.
In the podcast "Drug Story," host Thomas Goetz discusses how society often misuses medications like Ambien and Ozempic, highlighting a disconnect between drug use and bodily needs.
A recent U.S. military strike on a suspected drug boat in the Eastern Pacific resulted in six fatalities, contributing to a rising death toll linked to anti-drug operations.